SLKovid: Seroprevalence of SARS-CoV-2 in employees of a clinic with COVID-centre (COVID-19)
- Conditions
- SARS-COV-2-INFECTIONCOVID-19
- Registration Number
- DRKS00022226
- Lead Sponsor
- SLK-Kliniken Heilbronn GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Employees of SLK-Kliniken Heilbronn GmbH
Exclusion Criteria
No consent regarding study or parts of the study.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum analyses of antibodies against SARS-CoV-2 at 0 (if positive, additionalley at 3, 6 and 12 months) plus questionnaire
- Secondary Outcome Measures
Name Time Method Characterisation of the immune answer to SARS-CoV-2<br>Comparison of several commercially available CE-certified test Systems<br>Confirmation by neutralisation test<br>Analysis of infection rate by exposition and field of work<br>Evaluation of risk factors and prevention factors